Click on the links to read the full interview:

Dr Laurie Conklin -Vice President, Medical and Regulatory Affairs of ReveraGen Biopharma
Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
Click on the links to read the full interview:
Dr Laurie Conklin -Vice President, Medical and Regulatory Affairs of ReveraGen Biopharma
Multilingual WordPress with WPML